Empirical Finance’s CVS Health CVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $5.56M | Buy |
53,764
+1,510
| +3% | +$135K | 0.23% | 87 |
|
|
2026
Q1 | $3.75M | Sell |
52,254
-78
| -0.1% | -$6.01K | 0.18% | 117 |
|
|
2025
Q4 | $4.15M | Sell |
52,332
-1,906
| -4% | -$150K | 0.2% | 100 |
|
|
2025
Q3 | $4.09M | Buy |
54,238
+509
| +0.9% | +$34.9K | 0.19% | 108 |
|
|
2025
Q2 | $3.71M | Buy |
53,729
+295
| +0.6% | +$19.3K | 0.19% | 104 |
|
|
2025
Q1 | $3.62M | Buy |
53,434
+846
| +2% | +$50.6K | 0.22% | 94 |
|
|
2024
Q4 | $2.36M | Buy |
52,588
+7,959
| +18% | +$447K | 0.14% | 135 |
|
|
2024
Q3 | $2.81M | Buy |
44,629
+939
| +2% | +$54.8K | 0.16% | 116 |
|
|
2024
Q2 | $2.58M | Sell |
43,690
-3,045
| -7% | -$190K | 0.16% | 119 |
|
|
2024
Q1 | $3.73M | Buy |
46,735
+1,535
| +3% | +$117K | 0.23% | 96 |
|
|
2023
Q4 | $3.57M | Buy |
45,200
+149
| +0.3% | +$10.6K | 0.25% | 88 |
|
|
2023
Q3 | $3.15M | Buy |
45,051
+4,304
| +11% | +$305K | 0.23% | 95 |
|
|
2023
Q2 | $2.82M | Buy |
40,747
+4,196
| +11% | +$299K | 0.22% | 98 |
|
|
2023
Q1 | $2.72M | Buy |
36,551
+1,985
| +6% | +$166K | 0.25% | 86 |
|
|
2022
Q4 | $3.22M | Buy |
34,566
+2,933
| +9% | +$283K | 0.33% | 66 |
|
|
2022
Q3 | $3.02M | Buy |
31,633
+5,189
| +20% | +$514K | 0.36% | 57 |
|
|
2022
Q2 | $2.45M | Sell |
26,444
-4,994
| -16% | -$487K | 0.31% | 65 |
|
|
2022
Q1 | $3.18M | Buy |
31,438
+2,743
| +10% | +$288K | 0.36% | 56 |
|
|
2021
Q4 | $2.96M | Buy |
28,695
+559
| +2% | +$51.7K | 0.35% | 58 |
|
|
2021
Q3 | $2.39M | Sell |
28,136
-8,916
| -24% | -$747K | 0.36% | 50 |
|
|
2021
Q2 | $3.09M | Buy |
37,052
+6,424
| +21% | +$526K | 0.5% | 34 |
|
|
2021
Q1 | $2.09M | Hold |
30,628
| – | – | 0.37% | 68 |
|
|
2020
Q4 | $2.09M | Buy |
30,628
+2,347
| +8% | +$153K | 0.37% | 68 |
|
|
2020
Q3 | $1.65M | Buy |
28,281
+19,994
| +241% | +$1.24M | 0.35% | 75 |
|
|
2020
Q2 | $538K | Buy |
8,287
+1,069
| +15% | +$67.3K | 0.14% | 141 |
|
|
2020
Q1 | $428K | Buy |
7,218
+2,708
| +60% | +$181K | 0.13% | 135 |
|
|
2019
Q4 | $335K | Buy |
+4,510
| New | +$317K | 0.08% | 164 |
|
|
2017
Q4 | – | Sell |
-16,337
| Closed | -$1.33M | – | 114 |
|
|
2017
Q3 | $1.33M | Buy |
+16,337
| New | +$1.29M | 0.46% | 54 |
|
|
2017
Q1 | – | Sell |
-523
| Closed | -$42K | – | 201 |
|
|
2016
Q4 | $42K | Buy |
+523
| New | +$42.3K | 0.03% | 117 |
|
Other funds holding CVS
Empirical Finance's CVS Position: Q2 2026 in Review
Empirical Finance increased its CVS Health (CVS) stake by 2.9% in Q2 2026, buying an estimated $135K and bringing the position to 53,764 shares worth $5.56M. The position accounts for 0.23% of the portfolio, ranked #87.
Empirical Finance first reported a position in CVS in Q4 2016 and has held it in 29 quarters since. 2,067 funds tracked by Wall St. Rank hold CVS as of Q2 2026.
- Empirical Finance held 53,764 shares of CVS Health worth $5.56M as of Q2 2026.
- Empirical Finance bought 1,510 CVS Health shares in Q2 2026, an estimated $135K.
- CVS Health made up 0.23% of Empirical Finance's portfolio in Q2 2026, its #87 holding.
- Empirical Finance first reported a position in CVS Health in Q4 2016 and has held it in 29 quarters since.
- 2,067 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.
Based on Empirical Finance's 13F filing for Q2 2026, filed 14 Aug 2026.